| # | Drug | Count |
|---|---|---|
| 0 | LEVONORGESTREL | 7 |
| 1 | TERIPARATIDE | 6 |
| 2 | CISPLATIN | 5 |
| 3 | ETONOGESTREL | 5 |
| 4 | LEVOTHYROXINE SODIUM | 4 |
| 5 | ADALIMUMAB | 3 |
| 6 | CAPECITABINE | 3 |
| 7 | DOCETAXEL | 3 |
| 8 | DOCETAXEL ANHYDROUS | 3 |
| 9 | FLUOROURACIL | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CHLOROQUINE PHOSPHATE | 1 | 0.0015 |
| 1 | IMIGLUCERASE | 2 | 0.0004 |
| 2 | DEFLAZACORT | 1 | 0.0004 |
| 3 | CLINDAMYCIN PHOSPHATE | 1 | 0.0002 |
| 4 | GEFITINIB | 1 | 0.0001 |
| 5 | AGALSIDASE BETA | 1 | 0.0001 |
| 6 | LEUCOVORIN CALCIUM | 2 | 0.0001 |
| 7 | ETONOGESTREL AND ETHINYL ESTRADIOL | 2 | 0.0001 |
| 8 | ETONOGESTREL | 5 | 0.0001 |
| 9 | CISPLATIN | 5 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Progestin [EPC] | 14 |
| 1 | Platinum-based Drug [EPC] | 8 |
| 2 | Progestin-containing Intrauterine System [EPC] | 7 |
| 3 | Parathyroid Hormone Analog [EPC] | 6 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 5 |
| 5 | Benzodiazepine [EPC] | 3 |
| 6 | Corticosteroid [EPC] | 3 |
| 7 | Estrogen [EPC] | 3 |
| 8 | Interferon beta [EPC] | 3 |
| 9 | Microtubule Inhibitor [EPC] | 3 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 2 | 0.0003 |
| 1 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 1 | 0.0001 |
| 2 | Parathyroid Hormone Analog [EPC] | 6 | 0.0001 |
| 3 | Progestin [EPC] | 14 | 0.0000 |
| 4 | Intestinal Lipase Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Platinum-based Drug [EPC] | 8 | 0.0000 |
| 6 | HER2/neu Receptor Antagonist [EPC] | 2 | 0.0000 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 5 | 0.0000 |
| 8 | Microtubule Inhibitor [EPC] | 3 | 0.0000 |
| 9 | Estrogen [EPC] | 3 | 0.0000 |